CDMRP diversifies research funding through DoD

This spring the Department of Defense Congressionally Directed Medical Research Programs (CDMRP) released their FY23 pre-application and application deadlines for open funding opportunities. This program is housed under the Department of the Army and funds medical research with outcomes that not only benefit service members, beneficiaries, and veterans, but the general public as well. Their focus is to invest in groundbreaking research to address targeted critical gaps, and to support both the next generation of medical researchers as well as established scientists. Through this program, the full pipeline of research development is funded, including basic, translational and clinical research.

CDMRP uses a two-tier formal review with no standing peer review panels and no “pay line”. Consumer advocates are also involved throughout the program cycle. This opportunity is a conglomerate of multiple separate and more specific programs, each with their own different release dates and deadlines.

Investigators and researchers from a range of academic backgrounds are eligible to apply and eligibility is specific to each opportunity and type of grant. Once on the CDMRP’s site, view your interested program’s Synopsis of funding pdf to see investigator eligibility rules, release dates, pre-application and application deadlines for each type of grant.

Check out all of the CDMRP’s funded research programs here. Search past awards to see what kinds of research and technology they fund here, or look through their Impact Highlights Book to learn more about each program’s goals and some of their research success stories.

Read more about each program’s various open funding opportunities and guidelines and access their Synopsis of Funding document:

Applications and pre-applications for all programs are submitted electronically through the following sites:

To learn more about the CDMRP watch their program overview video.

Questions about this or other research funding?  Contact CTC.